The U.K.'s national screening committee has recommended routine abdominal aortic aneurysm screening with ultrasound for men over the age of 65. Doctors have welcomed the move but questioned the committee's decision not to screen women, according to an article in Pulse, a newspaper for general practitioners.
The U.K.'s national screening committee has recommended routine abdominal aortic aneurysm screening with ultrasound for men over the age of 65. Doctors have welcomed the move but questioned the committee's decision not to screen women, according to an article in Pulse, a newspaper for general practitioners.
The U.K.'s recommendation parallels a proposal last year by the U.S. Preventive Services Task Force to screen for AAA only in men between the ages of 65 and 75 who have ever smoked.
"The [U.K.] committee may well be justified in its decision to screen men only, but it will have to be prepared to communicate its reasons effectively, because there are bound to be concerns," said Phil Johnson, editor of Pulse. "Women are routinely less well treated for cardiovascular disease than men, and it would be a shame if a new and important innovation exacerbated that problem."
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.